Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Investing Activities (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Cash from Investing Activities for 7 consecutive years, with -$200000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Cash from Investing Activities fell 109.93% to -$200000.0 in Q3 2024 year-over-year; TTM through Jun 2025 was -$200000.0, a 102.11% decrease, with the full-year FY2024 number at $6.3 million, up 83.45% from a year prior.
  • Cash from Investing Activities was -$200000.0 for Q3 2024 at Creative Medical Technology Holdings, down from $6.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $6.5 million in Q1 2024 to a low of -$5.1 million in Q4 2022.
  • A 5-year average of -$51203.7 and a median of -$200000.0 in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 180.0% in 2021, then tumbled 2628.66% in 2022.
  • Creative Medical Technology Holdings' Cash from Investing Activities stood at -$250000.0 in 2020, then skyrocketed by 180.0% to $200000.0 in 2021, then crashed by 2628.66% to -$5.1 million in 2022, then surged by 118.47% to $933914.0 in 2023, then tumbled by 121.42% to -$200000.0 in 2024.
  • Per Business Quant, the three most recent readings for CELZ's Cash from Investing Activities are -$200000.0 (Q3 2024), $6.5 million (Q1 2024), and $933914.0 (Q4 2023).